LBO — TEXAS NEURO REHAB CENTER
IRR: 16.6% | MOIC: 2.16x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.6%
IRR
2.16x
MOIC
$46.0M
Entry EV
$69.4M
Exit EV
$23.7M
Equity Invested
Sources & Uses
S&UTotal · $46.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $17.9M | 38.8% | |
| Sub Debt | $4.5M | 9.7% | |
| Equity | $23.7M | 51.5% | |
| Enterprise Value | $44.7M | 97.1% | |
| Transaction Fees | $1.3M | 2.9% | |
| Total Uses | $46.0M | 100.0% |
Interpretation
INTAt 2.16x MOIC and 16.6% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $6.6M |
| Exit Ev | $69.4M |
| Net Debt At Exit | $18.3M |
| Equity At Exit | $51.1M |
| Equity Invested | $23.7M |
| Total Value Created | $27.4M |
| Value From Growth | $22.4M |
| Value From Multiple | $2.2M |
| Value From Deleveraging | $4.1M |